Recent efforts characterizing single-cell heterogeneity across 28 GBM tumors defined dominant cell states, which tumor cells can transition into and out of, with certain states being favored by cells having certain copy number aberrations (e.g., amplifications of CDK4, EGFR, and PDGFRA loci) [108]. The gene discussed is EGFR; the disease is glioblastoma.